Reliq Health Technologies Inc.

As of September 30, 2022, Reliq Health Technologies Inc. has 190.43M shares outstanding.

These figures are as of September 30, 2022. The price-to-sales ratio is 9.65, and the price-to-book ratio stands at 12.46.

These figures are as of September 30, 2022. The EV/Sales ratio of 9.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.

As of September 30, 2022, Reliq Health Technologies Inc. maintains a current ratio of 1.72, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.51, indicating elevated leverage, while an interest coverage ratio of -150.49 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2022, Reliq Health Technologies Inc. posted a negative return on equity (ROE) of -64.86, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -39.70, reflecting losses generated across the asset base. Inventory turnover of 14.98 indicates how many times Reliq Health Technologies Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2022, Reliq Health Technologies Inc. posted a gross margin of 60.65, reflecting its pricing power and cost economics. The operating margin of -45.95 and net profit margin of -39.20 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2022. Free cash flow yield is negative at -7.14: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.86, meaning Reliq Health Technologies Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Reliq Health Technologies Inc.'s most recent stock split took place on June 6, 2014 with a 5:1 split ratio.

As of September 30, 2022, Reliq Health Technologies Inc. has an Altman Z-Score of 3.40, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.